Clinical Trial

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 28, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study seeks to explore the effects of transcranial direct current stimulation (tDCS), a non-invasive method of brain stimulation, as an adjunctive treatment to improve antipsychotic medication adherence in patients with schizophrenia (SCZ). The investigators hypothesize that 20 sessions of tDCS will improve medication nonadherence in patients with SCZ.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-07-24; most recent amendment 2025-03-25.
Trial Details
NCT Number NCT04033679
Lead Sponsor Centre for Addiction and Mental Health
Conditions Schizophrenia;Schizoaffective
Enrollment 106 participants
Start Date 2019-08-15
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-28